Norway’s Crown Princess Mette-Marit placed on lung transplant list

Norway’s Crown Princess Mette-Marit has been placed on a lung transplant waiting list after extensive medical examinations showed that her pulmonary fibrosis had progressed to a serious stage. The Royal Court said she will not be able to work or carry out official engagements as normal while she waits for surgery, marking a prolonged interruption in the public role she has held since her illness was first disclosed in 2018.

Pulmonary fibrosis is a chronic disease that scars lung tissue and makes breathing increasingly difficult over time. It has no known cure. A lung specialist quoted by Norway’s public broadcaster said Mette-Marit’s condition had worsened significantly over the past six months, with scar tissue clearly increasing over the past year. The specialist also said patients are usually listed only when doctors believe the disease is severe enough that they may have about a year left to live without a transplant, although the hospital cannot predict when a suitable organ will become available.

In Norway, all lung transplants are performed at Rikshospitalet, part of Oslo University Hospital, and the country carries out about 30 such operations a year. The limiting factor is not the waiting list alone but the supply of usable donor lungs. Transplant timing depends on a compatible organ, including size and blood group, and the crown princess will not receive special royal priority in the allocation process. Hospital guidance says patients who receive a successful transplant can regain normal lung function and resume a normal daily life, though serious complications can still occur.

The medical crisis has unfolded under intense public attention. Princess Ingrid Alexandra returned from Australia to be with her mother, and Crown Prince Haakon shortened an official visit to Japan as the family gathered around her. The court’s announcement also comes after a difficult stretch for the royal household, including Mette-Marit’s February apology over scrutiny tied to Jeffrey Epstein contacts and the separate public focus on Marius Borg Høiby’s rape trial in Oslo that same month.

For Norway, the immediate issue is less the symbolism of the crown than the reality of chronic lung disease: a life-threatening condition, a finite pool of donor organs and an uncertain timetable that will keep the crown princess out of public life until treatment and rehabilitation are complete.